Neuphoria Therapeutics Inc. (NEUP): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$3.06

Year ended 2026-06-30

2023-06-30 EPS (Diluted) (USD per share) 2026-06-30

Period ended	EPS (Diluted)	Change YoY	Source filing
2026-06-30	-$3.06	n/m	2026-09-18, From 2025-07-01
2025-06-30	-$0.23	n/m	2026-09-18, From 2024-07-01
2024-06-30	-$18.62	n/m	2025-09-29, From 2023-07-01
2023-06-30	-$0.02	n/a	2024-09-30, From 2022-07-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EPS (Diluted)	Change YoY
Neuphoria Therapeutics Inc. (NEUP)	2026-06-30	-$3.06	n/m
Longeveron Inc. (LGVN)	2025-12-31	-$1.29	n/m
China SXT Pharmaceuticals, Inc. (SXTC)	2026-03-31	-$9.13	n/m
Vistagen Therapeutics, Inc. (VTGN)	2026-03-31	-$1.83	n/m
IGC Pharma, Inc. (IGC)	2025-03-31	-$0.09	n/m
Dare Bioscience, Inc. (DARE)	2025-12-31	-$1.20	n/m
Cannapharmarx, Inc. (CPMD)	2025-12-31	-$0.02	n/m
60 Degrees Pharmaceuticals, Inc. (SXTP)	2025-12-31	-$11.73	n/m
Northwest Biotherapeutics Inc (NWBO)	2025-12-31	-$0.04	n/m

Compare NEUP, LGVN, SXTC, VTGN side by side · Screen every company in Pharmaceutical Preparations ↗